Search
-
News
OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
… Thursday, November 4, 2021 The ability of doctors to match the correct treatment to a patient’s cancer just took a major step forward, when a genetic variant database developed at Memorial Sloan Kettering Cancer Center became the first to achieve partial recognition from the US Food and Drug Administration
-
News
Memorial Sloan Kettering Cancer Center physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research.
… Monday, September 14, 2009 Memorial Sloan Kettering Cancer Center (MSKCC) physician-scientist Charles L. Sawyers has been named a recipient of the 2009 Lasker~DeBakey Award for Clinical Medical Research. Dr. Sawyers is Chair of the Human Oncology and Pathogenesis Program (HOPP) within Memorial Hospital
-
News
Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.
… Thursday, June 6, 2024 If you’re diagnosed with cancer, your first instinct may be to get it treated right away because there’s not a moment to waste. But what if your doctor says you don’t need treatment? For some types of cancer, especially those that are early-stage and are unlikely to spread and
-
News
Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
… Monday, December 18, 2023 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatment for patients in 2023. The results from many cutting-edge clinical trials this year are leading to promising new treatments for brain cancer, colorectal cancer, bladder
-
News
Three students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 21.
… Friday, May 15, 2015 Three students at the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences have successfully defended their dissertations. As part of Memorial Sloan Kettering’s 36th annual academic convocation and the school’s fourth annual commencement on May 21, GSK will award PhD degrees
-
News
Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
… Thursday, March 2, 2017 Summary The Sloan Kettering Institute is home to many biologists who study basic biological processes fundamental to all cells. DNA replication and repair is an area where SKI excels. John Petrini , Chair of the Molecular Biology Program at SKI, is a world expert on the mechanics
-
News
Learn about a hospital-wide program that empowers children before they undergo surgery at Memorial Sloan Kettering.
… Friday, March 16, 2018 Summary A new program at Memorial Sloan Kettering is ensuring that our youngest patients get age-appropriate care before surgery . It’s before dawn in New York City, but the day is already well under way for Maria Martin. Ms. Martin is a child-life therapist at Memorial Sloan Kettering
-
News
Nine GSK PhD students were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).
… Friday, October 4, 2024 This past academic year, nine PhD students enrolled at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation
-
News
Learn about a noninvasive lung cancer test called "E-nose" that is being investigated at Memorial Sloan Kettering.
… Monday, July 8, 2024 Detecting lung cancer as early as possible has long been a goal of the specialists at MSK, because it gives doctors the most treatment options, which can improve outcomes for patients. A team led by MSK thoracic surgeon Gaetano Rocco, MD , reported results in a clinical trial
-
News
Conozca una prueba no invasiva para el cáncer pulmonar llamada “nariz electrónica” que está siendo investigada en Memorial Sloan Kettering.
… Monday, July 8, 2024 Detectar el cáncer pulmonar lo antes posible ha sido durante mucho tiempo un objetivo de los especialistas de MSK, ya que les brinda a los médicos más opciones de tratamiento, lo que puede mejorar los resultados para los pacientes. Un equipo dirigido por el cirujano torácico